Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02146274 · ClinicalTrials.gov registry record

Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research

A clinical trial of Stroke and Ischemic Stroke, sponsored by Duke University.

Completed
Registry status
1,877
Enrollment target
1
Study location

NCT02146274 is a study of Stroke and Ischemic Stroke that has completed, run by Duke University. The registered enrollment target is 1,877 participants, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02146274, a study of Stroke and Ischemic Stroke, has completed, sponsored by Duke University.

COMPLETED
Registry status
1,877 participants
Enrollment target
1
Study location

Study Summary

PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.

Conditions Studied

Study Locations (1)

North Carolina

  • Duke Clinical Research Institute - Durham

Trial Details

FieldValue
Enrollment Target 1,877 participants
Start Date 2013-11
Est. Completion 2017-12-31

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02146274

The ClinicalTrials.gov registry entry for NCT02146274 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,877 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (84% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT02146274 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02146274 about?

NCT02146274 is a clinical study titled "Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research". PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.

What is the current status of trial NCT02146274?

This trial is currently completed. The enrollment target is 1,877 participants. The study started on 2013-11. Estimated completion is 2017-12-31.

What conditions does trial NCT02146274 study?

This clinical trial studies the following conditions: Stroke, Ischemic Stroke.

Who is sponsoring clinical trial NCT02146274?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02146274 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.